Pierluigi Navarra

The role of small intestinal bacterial overgrowth in Parkinson's disease

Alfonso Fasano, Francesco Bove, Maurizio Gabrielli et al. · Movement Disorders · 2013 · 344 citations

Medicine, Clinical Sciences, Neurology +15

Interleukins-1 and -6 Stimulate the Release of Corticotropin-Releasing Hormone-41 from Rat Hypothalamus<i>in Vitro</i>via the Eicosanoid Cyclooxygenase Pathway*

Pierluigi Navarra, Stylianos Tsagarakis, Manuel dos Santos Faria et al. · Endocrinology · 1991 · 331 citations

Life Sciences, Endocrinology, Immunology +17

Intravesical Electromotive Mitomycin C Versus Passive Transport Mitomycin C for High Risk Superficial Bladder Cancer: A Prospective Randomized Study

Savino M. Di Stasi, Antonella Giannantoni, Robert Stephen et al. · The Journal of Urology · 2003 · 252 citations · Full text

Medicine, Oncology, Pharmacology +9

n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE 2 induced ERK-1 and -2 and HIF-1α induction pathway

Gabriella Calviello, Fiorella Di Nicuolo, Simona Gragnoli et al. · Carcinogenesis · 2004 · 245 citations · Full text

Medicine, Cancer Biology, Oncology +17

The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes

Lucia Lisi, Pierluigi Navarra, Douglas L. Feinstein et al. · Journal of Neuroinflammation · 2011 · 235 citations · Full text

Life Sciences, Neuroscience, Pharmacology +15